Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.

Rios M, Daniel S, Dayton AI, Wood O, Hewlett IK, Epstein JS, Caglioti S, Stramer SL.

J Infect Dis. 2008 Nov 1;198(9):1300-8. doi: 10.1086/592277.

PMID:
18771407
2.

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.

Tobler LH, Bianco C, Glynn SA, Schreiber GB, Dille BJ, Prince HE, Lanciotti RS, Linnen JM, Gallarda J, Shyamala V, Smith D, Kleinman SH, Busch MP; NHLBI Retrovirus Epidemiology Study (REDS).

Transfusion. 2005 Apr;45(4):480-6.

PMID:
15819666
3.

West Nile virus blood transfusion-related infection despite nucleic acid testing.

Macedo de Oliveira A, Beecham BD, Montgomery SP, Lanciotti RS, Linnen JM, Giachetti C, Pietrelli LA, Stramer SL, Safranek TJ.

Transfusion. 2004 Dec;44(12):1695-9.

PMID:
15584982
4.

Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.

Rios M, Zhang MJ, Grinev A, Srinivasan K, Daniel S, Wood O, Hewlett IK, Dayton AI.

Transfusion. 2006 Apr;46(4):659-67.

PMID:
16584445
5.

West Nile virus adheres to human red blood cells in whole blood.

Rios M, Daniel S, Chancey C, Hewlett IK, Stramer SL.

Clin Infect Dis. 2007 Jul 15;45(2):181-6. Epub 2007 Jun 12.

PMID:
17578776
6.

Virus and antibody dynamics in acute west nile virus infection.

Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, Matud JL, Prince HE, Lanciotti RS, Wright DJ, Linnen JM, Caglioti S.

J Infect Dis. 2008 Oct 1;198(7):984-93. doi: 10.1086/591467.

PMID:
18729783
7.

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH.

N Engl J Med. 2005 Aug 4;353(5):460-7.

8.

West Nile virus in Canadian blood donors.

Cameron C, Reeves J, Antonishyn N, Tilley P, Alport T, Eurich B, Towns D, Lane D, Saldanha J.

Transfusion. 2005 Apr;45(4):487-91.

PMID:
15819667
9.

Reacting to an emerging safety threat: West Nile virus in North America.

Stramer SL.

Dev Biol (Basel). 2007;127:43-58.

PMID:
17486880
10.

A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.

Biggerstaff BJ, Petersen LR.

Transfusion. 2009 Jun;49(6):1151-9. doi: 10.1111/j.1537-2995.2009.02112.x. Epub 2009 Feb 27.

PMID:
19309472
11.

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.

Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH.

Transfusion. 2005 Apr;45(4):492-9.

PMID:
15819668
12.

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection.

Ratterree MS, Gutierrez RA, Travassos da Rosa AP, Dille BJ, Beasley DW, Bohm RP, Desai SM, Didier PJ, Bikenmeyer LG, Dawson GJ, Leary TP, Schochetman G, Phillippi-Falkenstein K, Arroyo J, Barrett AD, Tesh RB.

J Infect Dis. 2004 Feb 15;189(4):669-76. Epub 2004 Feb 4.

PMID:
14767821
13.

West Nile virus among blood donors in the United States, 2003 and 2004.

Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY.

N Engl J Med. 2005 Aug 4;353(5):451-9.

14.
15.

Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening.

Lai L, Lee TH, Tobler L, Wen L, Shi P, Alexander J, Ewing H, Busch M.

Transfusion. 2012 Feb;52(2):447-54. doi: 10.1111/j.1537-2995.2011.03289.x. Epub 2011 Aug 9.

PMID:
21827506
16.

The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.

Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, Nemo G, Schreiber G, Bianco C, Katz L; NHLBI Retrovirus Epidemiology Study (REDS).

Transfusion. 2005 Apr;45(4):469-79.

PMID:
15819665
17.

West Nile virus transmission through blood transfusion--South Dakota, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Feb 2;56(4):76-9.

18.

Detection of West Nile virus in the Mexican blood supply.

Sánchez-Guerrero SA, Romero-Estrella S, Rodríguez-Ruiz A, Infante-Ramírez L, Gómez A, Villanueva-Vidales E, García-Torres M, Domínguez AM, Vázquez JA, Calderón ED, Valiente-Banuet L, Linnen JM, Broulik A, Harel W, Marín Y López RA.

Transfusion. 2006 Jan;46(1):111-7.

PMID:
16398739
19.

Persistence of antibodies to West Nile virus nonstructural protein 5.

Prince HE, Lapé-Nixon M, Yeh C, Tobler LH, Busch MP.

J Clin Virol. 2008 Sep;43(1):102-6. doi: 10.1016/j.jcv.2008.03.025. Epub 2008 May 8.

PMID:
18467165
20.

Persistence of West Nile virus-specific antibodies in viremic blood donors.

Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP.

Clin Vaccine Immunol. 2007 Sep;14(9):1228-30. Epub 2007 Jul 25.

Supplemental Content

Support Center